Jeffrey D. Browning
The University of Texas Southwestern Medical Center · 62 works · 15,193 citations · h-index 34
Top works
- Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
- Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population
- Molecular mediators of hepatic steatosis and liver injury
- Molecular mediators of hepatic steatosis and liver injury
- Ethnic Differences in the Prevalence of Cryptogenic Cirrhosis
- Increased De Novo Lipogenesis Is a Distinct Characteristic of Individuals With Nonalcoholic Fatty Liver Disease
- Excessive Hepatic Mitochondrial TCA Cycle and Gluconeogenesis in Humans with Nonalcoholic Fatty Liver Disease
- Ethnic differences in hepatic steatosis
- Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis
- Statins and hepatic steatosis: Perspectives from the Dallas Heart Study
- Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver
- Cytosolic Phosphoenolpyruvate Carboxykinase Does Not Solely Control the Rate of Hepatic Gluconeogenesis in the Intact Mouse Liver
- Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction
- Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver
- Gallstone disease and its complications.
- Pyruvate-Carboxylase-Mediated Anaplerosis Promotes Antioxidant Capacity by Sustaining TCA Cycle and Redox Metabolism in Liver
- The effect of short-term fasting on liver and skeletal muscle lipid, glucose, and energy metabolism in healthy women and men
- A high-fat diet suppresses de novo lipogenesis and desaturation but not elongation and triglyceride synthesis in mice
- Fasting reduces plasma proprotein convertase, subtilisin/kexin type 9 and cholesterol biosynthesis in humans
- Patatin-Like Phospholipase Domain-Containing 3 and the Pathogenesis and Progression of Pediatric Nonalcoholic Fatty Liver Disease